Cargando…

Nanopharmaceutics

Detalles Bibliográficos
Autor principal:	Ali, Javed
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Medknow Publications & Media Pvt Ltd 2011
Materias:	Editorial
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3465124/ https://www.ncbi.nlm.nih.gov/pubmed/23071922 http://dx.doi.org/10.4103/2230-973X.82382

Ejemplares similares

Opportunities and obstacles to the development of nanopharmaceuticals for human use
por: Nassiri Koopaei, Nasser, et al.
Publicado: (2016)

Trends in Nanopharmaceutical Patents
por: Antunes, Adelaide, et al.
Publicado: (2013)

Nanopharmaceuticals (part 1): products on the market
por: Weissig, Volkmar, et al.
Publicado: (2014)

Nanopharmaceuticals (part 2): products in the pipeline
por: Weissig, Volkmar, et al.
Publicado: (2015)

Emerging Nanopharmaceuticals and Nanonutraceuticals in Cancer Management
por: Salama, Lavinia, et al.
Publicado: (2020)

Use of Protamine in Nanopharmaceuticals—A Review
por: Ruseska, Ivana, et al.
Publicado: (2021)

Erratum to: Opportunities and obstacles to the development of nanopharmaceuticals for human use
por: Koopaei, Nasser Nassiri, et al.
Publicado: (2016)

Nanopharmaceuticals for Eye Administration: Sterilization, Depyrogenation and Clinical Applications
por: Zielińska, Aleksandra, et al.
Publicado: (2020)

Cancer Nanopharmaceuticals: Physicochemical Characterization and In Vitro/In Vivo Applications
por: Zielińska, Aleksandra, et al.
Publicado: (2021)

Glioblastoma-Derived Exosomes as Nanopharmaceutics for Improved Glioma Treatment
por: Lee, Hyeji, et al.
Publicado: (2022)

Application of Nanopharmaceutics for Flibanserin Brain Delivery Augmentation Via the Nasal Route
por: Ahmed, Osama A. A., et al.
Publicado: (2020)

Nanopharmaceutics: Part II—Production Scales and Clinically Compliant Production Methods
por: Souto, Eliana B., et al.
Publicado: (2020)

Spray-dried lactose-leucine microparticles for pulmonary delivery of antimycobacterial nanopharmaceuticals
por: Thiyagarajan, Durairaj, et al.
Publicado: (2021)

CRLX101 (formerly IT-101)–A Novel Nanopharmaceutical of Camptothecin in Clinical Development
por: Young, Cissy, et al.
Publicado: (2011)

Assessment of multifunctional contrast agent probes in neuroimaging: Implications of nanopharmaceutical therapeutic interventions
por: Machtoub, Lina H.
Publicado: (2013)

Nanopharmaceutics: Part I—Clinical Trials Legislation and Good Manufacturing Practices (GMP) of Nanotherapeutics in the EU
por: Souto, Eliana B., et al.
Publicado: (2020)

Drug Delivery From Polymer-Based Nanopharmaceuticals—An Experimental Study Complemented by Simulations of Selected Diffusion Processes
por: Macha, Innocent J., et al.
Publicado: (2019)

A hybrid nanopharmaceutical for specific-amplifying oxidative stress to initiate a cascade of catalytic therapy for pancreatic cancer
por: Liu, Fan, et al.
Publicado: (2023)

Towards potent but less toxic nanopharmaceuticals – lipoic acid bioconjugates of ultrasmall gold nanoparticles with an anticancer drug and addressing unit
por: Dzwonek, Maciej, et al.
Publicado: (2018)

Development and evaluation of vitamin E d-α-tocopheryl polyethylene glycol 1000 succinate-mixed polymeric phospholipid micelles of berberine as an anticancer nanopharmaceutical
por: Shen, Roger, et al.
Publicado: (2016)

Novel multi-component nanopharmaceuticals derived from poly(ethylene) glycol, retro-inverso-Tat nonapeptide and saquinavir demonstrate combined anti-HIV effects
por: Wan, Li, et al.
Publicado: (2006)

Bombesin Peptide Conjugated Water-Soluble Chitosan Gallate—A New Nanopharmaceutical Architecture for the Rapid One-Pot Synthesis of Prostate Tumor Targeted Gold Nanoparticles
por: Tangthong, Theeranan, et al.
Publicado: (2021)

Nanopharmaceutical Approach for Enhanced Anti-cancer Activity of Betulinic Acid in Lung-cancer Treatment via Activation of PARP: Interaction with DNA as a Target: -Anti-cancer Potential of Nano-betulinic Acid in Lung Cancer-
por: Das, Jayeeta, et al.
Publicado: (2016)

Plagiarism: An editor's concern
por: Ali, Javed
Publicado: (2011)

Scope of nano ophthalmology
por: Ali, Javed
Publicado: (2011)

Thank you authors and reviewers
por: Ali, Javed
Publicado: (2012)

Lacrimal surgery: Glorious past, exciting present era and the audacity of hope for a brilliant future
por: Ali, Mohammad Javed
Publicado: (2014)

Electron microscopy in the understanding of lacrimal drainage system
por: Ali, Mohammad Javed
Publicado: (2015)

The science of dacryology – Need of the hour
por: Javed Ali, Mohammad
Publicado: (2017)

The launch of International Journal of Pharmaceutical Investigation
por: Ali, Javed, et al.
Publicado: (2011)

The environmental needs of clinician-scientists in ophthalmology
por: Ali, Mohammad Javed, et al.
Publicado: (2017)

Manuscript Rejection: Causes and Remedies
por: Ali, Javed
Publicado: (2010)

The SARS-CoV-2, tears, and ocular surface debate: What we know and what we need to know
por: Ali, Mohammad Javed
Publicado: (2020)

Innate human resilience and COVID-19: Help from an old friend to beat the new enemy
por: Ali, Mohammad Javed
Publicado: (2020)

Impact factor under attack! Are the criticisms justified?
por: Ali, Mohammad Javed
Publicado: (2021)

Predatory journals and conferences: Analysis of invitation emails from a single clinician-scientist’s inbox
por: Ali, Mohammad Javed
Publicado: (2021)

Holding back the tears: does marsupialisation of a remnant canaliculus after tumour resection help eliminate epiphora?
por: Ali, Mohammad Javed, et al.
Publicado: (2022)

Rising JCV-Ab index during natalizumab therapy for MS: Inauspicious for a highly efficacious drug
por: Javed, Adil, et al.
Publicado: (2016)

Passive Leg Raising for Fluid Responsiveness in Children: Is it Reliable?
por: Ismail, Javed, et al.
Publicado: (2020)

Empagliflozin, calcium, and SGLT1/2 receptor affinity: another piece of the puzzle
por: Anker, Stefan D., et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_ei2np51pbss4op42r51stftf75